ステムセル研究所の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2025/08/27 | 1,005 | 1,005 | 981 | 984 | -23 | -2.3% | 64,700 |
| 2025/08/26 | 1,012 | 1,025 | 1,002 | 1,007 | +10 | +1% | 57,700 |
| 2025/08/25 | 1,016 | 1,016 | 995 | 997 | -16 | -1.6% | 46,600 |
| 2025/08/22 | 1,021 | 1,025 | 1,005 | 1,013 | -12 | -1.2% | 62,700 |
| 2025/08/21 | 1,021 | 1,039 | 1,005 | 1,025 | +2 | +0.2% | 79,000 |
| 2025/08/20 | 1,044 | 1,044 | 1,016 | 1,023 | -10 | -1% | 45,400 |
| 2025/08/19 | 1,049 | 1,085 | 1,031 | 1,033 | +1 | +0.1% | 128,100 |
| 2025/08/18 | 1,020 | 1,047 | 1,017 | 1,032 | +20 | +2% | 75,900 |
| 2025/08/15 | 1,048 | 1,059 | 1,007 | 1,012 | -29 | -2.8% | 121,800 |
| 2025/08/14 | 998 | 1,051 | 997 | 1,041 | +40 | +4% | 100,300 |
| 2025/08/13 | 998 | 1,008 | 994 | 1,001 | +2 | +0.2% | 31,700 |
| 2025/08/12 | 1,007 | 1,007 | 990 | 999 | -8 | -0.8% | 39,100 |
| 2025/08/08 | 1,029 | 1,030 | 995 | 1,007 | -13 | -1.3% | 43,600 |
| 2025/08/07 | 1,013 | 1,030 | 1,011 | 1,020 | +1 | +0.1% | 32,700 |
| 2025/08/06 | 1,008 | 1,030 | 1,007 | 1,019 | +12 | +1.2% | 31,900 |
| 2025/08/05 | 1,004 | 1,019 | 1,001 | 1,007 | +4 | +0.4% | 18,800 |
| 2025/08/04 | 996 | 1,012 | 991 | 1,003 | -14 | -1.4% | 27,800 |
| 2025/08/01 | 1,019 | 1,022 | 1,000 | 1,017 | -2 | -0.2% | 29,700 |
| 2025/07/31 | 1,012 | 1,030 | 1,011 | 1,019 | +8 | +0.8% | 43,400 |
| 2025/07/30 | 1,017 | 1,031 | 1,010 | 1,011 | -5 | -0.5% | 41,700 |
| 2025/07/29 | 1,023 | 1,030 | 1,016 | 1,016 | -12 | -1.2% | 36,700 |
| 2025/07/28 | 1,021 | 1,041 | 1,021 | 1,028 | +8 | +0.8% | 34,300 |
| 2025/07/25 | 1,047 | 1,047 | 1,018 | 1,020 | -13 | -1.3% | 30,800 |
| 2025/07/24 | 1,023 | 1,054 | 1,021 | 1,033 | +10 | +1% | 54,000 |
| 2025/07/23 | 1,008 | 1,035 | 1,008 | 1,023 | +16 | +1.6% | 86,300 |
| 2025/07/22 | 1,019 | 1,026 | 990 | 1,007 | -17 | -1.7% | 83,700 |
| 2025/07/18 | 1,036 | 1,045 | 1,009 | 1,024 | -11 | -1.1% | 105,400 |
| 2025/07/17 | 1,050 | 1,072 | 1,017 | 1,035 | -13 | -1.2% | 309,500 |
| 2025/07/16 | 1,195 | 1,245 | 1,032 | 1,048 | -58 | -5.2% | 1,529,300 |
| 2025/07/15 | 956 | 1,106 | 938 | 1,106 | +150 | +15.7% | 182,700 |
| 2025/07/14 | 950 | 957 | 938 | 956 | +6 | +0.6% | 29,000 |
| 2025/07/11 | 953 | 956 | 937 | 950 | +6 | +0.6% | 44,600 |
| 2025/07/10 | 925 | 951 | 917 | 944 | +19 | +2.1% | 60,300 |
| 2025/07/09 | 938 | 940 | 925 | 925 | -14 | -1.5% | 40,100 |
| 2025/07/08 | 911 | 941 | 911 | 939 | +28 | +3.1% | 43,700 |
| 2025/07/07 | 941 | 941 | 911 | 911 | -34 | -3.6% | 64,600 |
| 2025/07/04 | 951 | 956 | 943 | 945 | -1 | -0.1% | 27,700 |
| 2025/07/03 | 962 | 964 | 945 | 946 | -16 | -1.7% | 61,800 |
| 2025/07/02 | 990 | 990 | 950 | 962 | -34 | -3.4% | 95,000 |
| 2025/07/01 | 1,004 | 1,014 | 993 | 996 | -2 | -0.2% | 48,500 |
| 2025/06/30 | 1,002 | 1,006 | 995 | 998 | -8 | -0.8% | 56,900 |
| 2025/06/27 | 1,005 | 1,016 | 1,001 | 1,006 | ±0 | ±0% | 30,900 |
| 2025/06/26 | 1,012 | 1,012 | 1,004 | 1,006 | -1 | -0.1% | 21,700 |
| 2025/06/25 | 1,018 | 1,018 | 1,000 | 1,007 | -13 | -1.3% | 27,800 |
| 2025/06/24 | 1,015 | 1,036 | 1,010 | 1,020 | +8 | +0.8% | 18,400 |
| 2025/06/23 | 1,038 | 1,038 | 1,011 | 1,012 | -17 | -1.7% | 23,500 |
| 2025/06/20 | 1,051 | 1,051 | 1,027 | 1,029 | -16 | -1.5% | 35,700 |
| 2025/06/19 | 1,066 | 1,066 | 1,045 | 1,045 | -11 | -1% | 20,700 |
| 2025/06/18 | 1,066 | 1,087 | 1,056 | 1,056 | -22 | -2% | 39,500 |
| 2025/06/17 | 1,096 | 1,099 | 1,067 | 1,078 | +8 | +0.7% | 23,300 |
1～
50
件表示中 / 1022件
類似銘柄と比較する
現在ご覧いただいている「ステムセル研」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ステムセル研 | 99,100円 | +12.0% | +5.1% | 0.00% | 31.18倍 | 3.80倍 |
|
臍帯血の処理・保管の細胞バンク事業で国内民間市場ほぼ独占。臍帯保管や新規事業に展開図る |
| ウエスコＨＤ | 75,300円 | +1.9% | -8.3% | 2.92% | 15.15倍 | 0.64倍 |
|
西日本地盤の総合建設コンサル。測量・地質調査。スポーツ施設、水族館運営も。１４年持株会社化 |
| プログレス | 130,200円 | +10.4% | +85.3% | 0.00% | 9.23倍 | 2.77倍 |
|
製造業向けにデジタルツイン活用の設計開発技術やコンサルサービス提供。エンジニア派遣も |
| リベロ | 187,600円 | +30.2% | +68.8% | 1.60% | 18.64倍 | 4.04倍 |
|
引っ越しや新生活に必要な手続き支援サービスに競争力、不動産会社や一般法人向けが収益柱 |
| ＭＤＮＴ | 3,900円 | +21.1% | - | 0.00% | - | 2.33倍 |
|
東大医科研発。がん免疫細胞療法の細胞加工が核。医薬品開発、医薬品受託製造（ＣＤＭＯ）も |
市場注目の銘柄
チャート関連のコラム
